Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2023 – Jun 2025Where it's discussed
-
X / Twitter6 posts
-
News4 articles
-
YouTube2 videos
AI synopsis
What people are saying
Participants demonstrate moderate agreement and engagement by discussing the nuances of regional guidelines for HCC, particularly emphasizing Taiwan's unique management strategies, as seen in comments referencing the 'Taiwan perspective' and comparing it to other regions like Japan and China. The tone combines professional analysis with a recognition of regional differences, reflecting a balanced view of the publication’s relevance.
Most comments align positively with the publication, highlighting the importance of these regional perspectives and acknowledging the value of tailored guidelines.
The discussions reflect moderate interest, with participants expressing curiosity about regional differences in managing HCC and noting the relevance to Taiwan’s healthcare context.
Posts include specific references to guidelines and case management, indicating a thoughtful level of engagement and analysis.
The discussions suggest that the publication influences clinical perspectives and may inform local practice improvements, but the overall impact is seen as moderate given the focus on regional nuances.
Abstract in brief
- Hepatocellular carcinoma (HCC) is a major health issue in Taiwan, being the fourth most common cancer and a leading cause of cancer-related death, with management guided by national guidelines and policies.
- Surveillance for HCC involves regular abdominal ultrasounds and blood tests, with advanced imaging like CT or MRI recommended for high-risk or difficult cases; diagnosis usually relies on dynamic imaging and sometimes pathology.
- Treatment strategies include curative options like surgery and locoregional therapies for certain patients, with systemic therapies such as sorafenib or lenvatinib being reimbursed, and emerging approaches like early switching to systemic therapy for TACE-refractory cases reflecting recent shifts in management.
Top posts
Most liked on X and BlueskyClinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g
RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g
RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2
RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40
All mentions
Hepatocellular Carcinoma Management: Guidelines and Clinical Practices in Taiwan
Hepatocellular carcinoma is a major health issue in Taiwan, with management guided by national guidelines, including surveillance, diagnosis, and treatment strategies such as surgery, locoregional therapies, and…
Clinical Practice and Real-Life Management of Liver Cancer in Taiwan
This video discusses hepatocellular carcinoma management in Taiwan, focusing on national guidelines, surveillance methods, diagnostic procedures, and treatment options including surgery, locoregional therapies, and…
RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g
RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2
RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g